- /
- Supported exchanges
- / US
- / NPCE.NASDAQ
Neuropace Inc (NPCE NASDAQ) stock market data APIs
Neuropace Inc Financial Data Overview
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Neuropace Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Neuropace Inc data using free add-ons & libraries
Get Neuropace Inc Fundamental Data
Neuropace Inc Fundamental data includes:
- Net Revenue: 107 M
- EBITDA: -11 877 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-11
- EPS/Forecast: -0.19
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neuropace Inc News
New
Why Is NeuroPace (NPCE) Down 0.4% Since Last Earnings Report?
It has been about a month since the last earnings report for NeuroPace, Inc. (NPCE). Shares have lost about 0.4% in that time frame, outperforming the S&P 500. Will the recent negative trend continue...
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
NeuroPace, Inc. NPCE is well-positioned for solid growth, driven by strong RNS adoption, favorable RNS reimbursement, expanding referral networks and AI-driven innovations that enhance efficiency and ...
NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth
NeuroPace, Inc. NPCE has hit a regulatory delay in its bid to expand the RNS System into idiopathic generalized epilepsy, or IGE. The FDA's July 2026 response pushes out a potential growth catalyst be...
Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated?
NeuroPace, Inc. NPCE is showing better operating momentum as RNS System adoption expands and losses narrow. Second-quarter results supported the growth case, while a broader commercial reach and new t...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.